Primary Fallopian Tube Carcinoma Presenting with a Massive Inguinal Tumor: A Case Report and Literature Review

Medicina (Kaunas). 2022 Apr 23;58(5):581. doi: 10.3390/medicina58050581.

Abstract

Primary fallopian tube carcinoma (PFTC) has characteristics similar to those of ovarian carcinoma. The typical course of PFTC metastasis includes peritoneal dissemination and pelvic and paraaortic lymph node metastasis, while inguinal lymph node metastasis is rare. Moreover, the initial presentation of PFTC with an inguinal tumor is extremely rare. A 77-year-old postmenopausal woman presented with a massive 12-cm inguinal subcutaneous tumor. After tumor resection, histopathological and immunohistochemical analysis showed that the tumor was a high-grade serous carcinoma of gynecological origin. Subsequent surgery for total hysterectomy with bilateral salpingo-oophorectomy revealed that the tumor developed in the fallopian tube. She received adjuvant chemotherapy with carboplatin and paclitaxel, followed by maintenance therapy with niraparib. There has been no recurrence or metastasis 9 months after the second surgery. We reviewed the literature for cases of PFTC and ovarian carcinoma that initially presented with an inguinal tumor. In compliance with the Preferred Reporting Items for Systematic Reviews guidelines, a systematic literature search was performed through 31 January 2022 using the PubMed and Google scholar databases and identified 14 cases. In half of them, it was difficult to identify the primary site using preoperative imaging modalities. Disease recurrence occurred in two cases; thus, the prognosis of this type of PFTC appears to be good.

Keywords: inguinal lymph node metastasis; inguinal tumor; primary fallopian tube carcinoma; serous carcinoma.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Carcinoma*
  • Fallopian Tube Neoplasms* / complications
  • Fallopian Tube Neoplasms* / pathology
  • Fallopian Tube Neoplasms* / surgery
  • Fallopian Tubes
  • Female
  • Humans
  • Lymphatic Metastasis
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms* / complications
  • Ovarian Neoplasms* / surgery

Grants and funding

This research received no external funding.